Hello and welcome! This "beginner workout" is made just for you if you're over 40 and seeking effective, "joint friendly workout" options. In just 15-20 minutes, this "yoga at home" session will help ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

Jelly Roll was a recent guest on the Joe Rogan Experience podcast where he revealed something about his major weight loss transformation that he hasn't yet before. The "Son Of A Sinner" singer says ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Ascletis Pharma has posted 7.7% weight loss for the highest dose of its own entrant in the highly contested oral GLP-1 race. The Chinese biotech evaluated three different once-daily doses of its oral ...

Share on Pinterest A new study found that a 4-week alternate-day fasting protocol showed significant reductions in body fat, but also muscle mass. Lumina/Stocksy Researchers report that alternate-day ...

Ryan Day and the Ohio State Buckeyes suffered their first loss of the season on Saturday night, falling in the Big Ten championship game to the Indiana Hoosiers by a final score of 13-10. In a hotly ...

(NEXSTAR) – The World Health Organization has issued new guidance on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro, and Zepbound, to treat the “major global health challenge” of ...

Ash-har Quraishi is a consumer correspondent based in Chicago. He is an Emmy Award-winning journalist with more than 25 years of local, national, international and investigative reporting experience.